Magazine Article | June 7, 2017

The Power of Small Wins — And How to Keep Them Going

By Teresa Amabile, Baker Foundation Professor and Research Director at Harvard Business School

Consider two facts. One: Many senior scientists and engineers in biopharma, during careers of 20, 30, even 40 years, have never been directly involved in developing a commercially successful drug. Not once. Two: Of all the things that can keep people engaged and productive in meaningful creative work — like discovering groundbreaking disease treatments — the single most important is simply making progress. Because drug R&D is likely to remain difficult even as technology advances, the challenge for you, as a leader, is this: How do you maintain the motivation of talented researchers, young and old, when progress is slow?

THIS CONTENT IS EXCLUSIVELY FOR LIFE SCIENCE LEADER PAID SUBSCRIBERS.
To continue reading this story and receive uninterrupted access to LSL Online and its monthly magazine subscribe to Life Science Leader today!
Already a subscriber? Log in now.